Effect of octreotide acetate combined with alprostadil on serum inflammatory factors of hepatitis B cirrhosis patients complicated with hepatorenal syndrome

CHEN Ying; LI Jichang; LIU Haixia; WU Yumei; XUE Ting

doi:10.7619/jcmp.201821018

CHEN Ying, LI Jichang, LIU Haixia, WU Yumei, XUE Ting. Effect of octreotide acetate combined with alprostadil on serum inflammatory factors of hepatitis B cirrhosis patients complicated with hepatorenal syndrome[J]. Journal of Clinical Medicine in Practice, 2018, (21): 58-60,64. DOI: 10.7619/jcmp.201821018

Citation:

CHEN Ying, LI Jichang, LIU Haixia, WU Yumei, XUE Ting. Effect of octreotide acetate combined with alprostadil on serum inflammatory factors of hepatitis B cirrhosis patients complicated with hepatorenal syndrome[J]. Journal of Clinical Medicine in Practice, 2018, (21): 58-60,64. DOI: 10.7619/jcmp.201821018

Citation:

CHEN Ying, LI Jichang, LIU Haixia, WU Yumei, XUE Ting. Effect of octreotide acetate combined with alprostadil on serum inflammatory factors of hepatitis B cirrhosis patients complicated with hepatorenal syndrome[J]. Journal of Clinical Medicine in Practice, 2018, (21): 58-60,64. DOI: 10.7619/jcmp.201821018

Effect of octreotide acetate combined with alprostadil on serum inflammatory factors of hepatitis B cirrhosis patients complicated with hepatorenal syndrome

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Effect of octreotide acetate combined with alprostadil on serum inflammatory factors of hepatitis B cirrhosis patients complicated with hepatorenal syndrome

Catalog

Export File

Citation

Format

Content